Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vascular tumor targeting.

J Ahlskog¹, G Paganelli, D Neri

¹Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of

|October 18, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumor-targeted IL2 promotes specific CD8<sup>+</sup> T cells private clonal expansion enhancing lymphoma control.

Journal of experimental & clinical cancer research : CR·2026

Same author

Past, present and future of drug conjugates for cancer therapy.

Nature cancer·2025

Same author

Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Editorial: Plant root interaction with associated microbiomes to improve plant resiliency and crop biodiversity, volume II.

Frontiers in plant science·2023

Same author

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [<sup>68</sup>Ga]Ga-OncoFAP-DOTAGA.

European journal of nuclear medicine and molecular imaging·2021

Same author

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.

ESMO open·2021

Same journal

Evidence-based data on PET in infectious and inflammatory diseases.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026

Same journal

Evidence-based PET in cardiovascular infectious diseases: an umbrella review.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026

Same journal

Evidence-based role of PET imaging in cardiac and systemic sarcoidosis: an umbrella review of the current literature.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026

Same journal

Response assessment in [177Lu]PSMA: where do we stand?

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026

Same journal

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026

Same journal

Radionuclide lung scintigraphy in the evaluation of suspected acute and chronic pulmonary embolism: methods, interpretation, and lexicon. A basic user guide for the clinician.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026

See all related articles

Targeting tumor blood vessels, or vascular targeting, is an effective anti-tumor strategy. This approach complements anti-angiogenic therapies by destroying established tumor vasculature, showing promise in animal models for future clinical applications.

Area of Science:

Oncology
Vascular Biology
Drug Development

Background:

Solid tumor growth relies on neovascularization (new blood vessel formation).
Anti-angiogenic agents inhibit this process, but tumor vasculature remains a target.
Targeting established tumor vasculature offers a complementary therapeutic strategy.

Purpose of the Study:

To review evidence supporting vascular tumor targeting as an anti-tumor strategy.
To describe methods for identifying vascular targets in tumors.
To discuss future clinical applications of vascular targeting.

Main Methods:

Review of preclinical data on vascular tumor targeting in animal models.
Analysis of strategies for identifying tumor vascular targets.

Related Experiment Videos

Discussion of clinical translation prospects.

Main Results:

Vascular tumor targeting demonstrates efficacy as an anti-tumor strategy in animal models.
Various strategies exist for identifying specific tumor vascular targets.
The approach holds potential for clinical application.

Conclusions:

Vascular tumor targeting is a validated anti-tumor approach in preclinical settings.
Further research into target identification and clinical strategies is warranted.
This therapeutic avenue complements existing anti-angiogenic treatments.